Solitons

SOLITON INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Soliton, Inc. - SOLY

Retrieved on: 
Wednesday, May 12, 2021
Legal, Professional services, Calculus, Differential equations, Multivariable calculus, Foti, Fluid dynamics, Solitons, Quasiparticles, Nonlinear optics, AbbVie, KSF

b'Former Attorney General of Louisiana Charles C. Foti, Jr., Esq.

Key Points: 
  • b'Former Attorney General of Louisiana Charles C. Foti, Jr., Esq.
  • and the law firm of Kahn Swick & Foti, LLC (\xe2\x80\x9cKSF\xe2\x80\x9d) are investigating the proposed sale of Soliton, Inc. (NasdaqGS: SOLY) to AbbVie, Inc. (NYSE: ABBV).
  • Under the terms of the proposed transaction, shareholders of Soliton will receive only $22.60 in cash for each share of Soliton that they own.
  • KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company.\nIf you believe that this transaction undervalues the Company and/or if you would like to discuss your legal rights regarding the proposed sale, you may, without obligation or cost to you, e-mail or call KSF Managing Partner Lewis S. Kahn ( [email protected] ) toll free at any time at 855-768-1857, or visit https://www.ksfcounsel.com/cases/nasdaqgs-soly/ to learn more.\nTo learn more about KSF, whose partners include the Former Louisiana Attorney General, visit www.ksfcounsel.com .\nView source version on businesswire.com: https://www.businesswire.com/news/home/20210512006041/en/\n'

Soliton Announces Oral Presentation at American Society for Laser Medicine and Surgery Virtual Annual Conference

Retrieved on: 
Tuesday, April 27, 2021
Optics, Calculus, Nonlinear optics, Cosmetic surgery, Solitons, Laser medicine, Fluid dynamics, Cellulite, Laser, Tattoo removal

b'HOUSTON, April 27, 2021 /PRNewswire/ --Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology, today announced that the 52-week results from its pivotal cellulite trial have been accepted for an oral presentation at the American Society for Laser Medicine and Surgery Virtual Annual Conference, held May 15-16, 2021.\n"We are honored to present new long-term cellulite data at the ASLMS annual conference.

Key Points: 
  • b'HOUSTON, April 27, 2021 /PRNewswire/ --Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology, today announced that the 52-week results from its pivotal cellulite trial have been accepted for an oral presentation at the American Society for Laser Medicine and Surgery Virtual Annual Conference, held May 15-16, 2021.\n"We are honored to present new long-term cellulite data at the ASLMS annual conference.
  • "We look forward to sharing these results in front of the well-respected industry members and community attending ASLMS.
  • The Company believes this "Soliton" method has the potential to lower tattoo removal costs for patients, while increasing profitability to practitioners, compared to current laser removal methods.
  • Forward-looking statements in this press release include, without limitation, our ability to effectively treat cellulite with long-term results.

Soliton Named Best New Technology Award at the Aesthetic Industry Association Board Meeting

Retrieved on: 
Thursday, February 18, 2021
Calculus, Differential equations, Multivariable calculus, Solitons, Nonlinear optics

HOUSTON, Feb. 18, 2021 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology, today announced that the company's Rapid Acoustic Pulse (RAP) device received the Best New Technology Award from the Aesthetic Industry Association (AIA).

Key Points: 
  • HOUSTON, Feb. 18, 2021 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology, today announced that the company's Rapid Acoustic Pulse (RAP) device received the Best New Technology Award from the Aesthetic Industry Association (AIA).
  • The Soliton RAP device uses proprietary design acoustic shockwaves to mechanically disrupt targeted cellular structures in a completely non-invasive therapy.
  • "We are honored to be the first recipient of this award from the Aesthetic Industry Association.
  • We are thrilled to have our innovative technology recognized in this manner by industry peers and leaders.

Soliton Announces FDA Clearance of Rapid Acoustic Pulse Technology for Use in Cellulite

Retrieved on: 
Monday, February 1, 2021
Calculus, Differential equations, Multivariable calculus, Quasiparticles, Solitons

"We're thrilled to receive this latest clearance for our RAP technology," said Brad Hauser, President & CEO of Soliton.

Key Points: 
  • "We're thrilled to receive this latest clearance for our RAP technology," said Brad Hauser, President & CEO of Soliton.
  • Soliton RAP technology also received 510(k) clearance from the FDA for the removal of tattoos in mid 2019.
  • The Company is based in Houston, Texas, and is actively engaged in bringing the Rapid Acoustic Pulse ("RAP") device to the market.
  • The Company also believes the technology will provide the first non-invasive acoustic technology to be able to target the underlying cause of dimples and ridges in cellulite.

Workday Announces Intent to Acquire Peakon

Retrieved on: 
Thursday, January 28, 2021
Articles, Labor, Workday, Inc., Solitons, Employment, Employee engagement, Peakon

PLEASANTON, Calif., Jan. 28, 2021 (GLOBE NEWSWIRE) -- Workday, Inc. (NASDAQ:WDAY), a leader in enterprise cloud applications for finance and human resources , and Peakon ApS , an employee success platform that converts feedback into actionable insights, have signed a definitive agreement under which Workday will acquire Peakon in an all-cash transaction.

Key Points: 
  • PLEASANTON, Calif., Jan. 28, 2021 (GLOBE NEWSWIRE) -- Workday, Inc. (NASDAQ:WDAY), a leader in enterprise cloud applications for finance and human resources , and Peakon ApS , an employee success platform that converts feedback into actionable insights, have signed a definitive agreement under which Workday will acquire Peakon in an all-cash transaction.
  • With Peakon, Workday will provide organizations with a continuous listening platform, including real-time visibility into employee experience, sentiment, and productivity, to help drive employee engagement and improve organizational performance.
  • These circumstances have forced organizations to rethink HR strategies and continually adapt approaches to engage, support, and retain talent.
  • To meet this moment, Workday and Peakon will come together with a continuous listening platform that will help customers capture real-time employee sentiment, facilitate ongoing feedback, and access personalized, prescriptive recommendations for actions.

Soliton Appoints Sean J. Shapiro as Vice President of Sales

Retrieved on: 
Wednesday, December 30, 2020
Calculus, Differential equations, Multivariable calculus, Nonlinear optics, Solitons, Laser medicine, Tattoo removal, Tattooing

HOUSTON, Dec. 30, 2020 /PRNewswire/ --Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology, today announced the appointment of Sean J. Shapiro as Vice President of Sales, effective January 1, 2021.

Key Points: 
  • HOUSTON, Dec. 30, 2020 /PRNewswire/ --Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology, today announced the appointment of Sean J. Shapiro as Vice President of Sales, effective January 1, 2021.
  • Most recently, Mr. Shapiro was Vice President of Commercial Operations at Viveve Inc., a Women's Health Company which manufactures patented CMRF Technology, where he recruited a sales team which generated approximately $11 million in revenue in the year of launch.
  • The Company is based in Houston, Texas, and is actively engaged in bringing the Rapid Acoustic Pulse ("RAP") device to the market.
  • The Company believes this "Soliton" method has the potential to lower tattoo removal costs for patients, while increasing profitability to practitioners, compared to current laser removal methods.

Soliton Appoints Aesthetic Executive Veteran Brad Hauser as President and Chief Executive Officer in Preparation for Commercial Launch

Retrieved on: 
Monday, November 2, 2020
Calculus, Differential equations, Multivariable calculus, Fluid dynamics, Solitons, Inflation, Large-scale structure of the cosmos, Topological defect

HOUSTON, Nov. 2, 2020 /PRNewswire/ --Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary aesthetic platform technology, today announced the appointment of Brad A. Hauser as President and Chief Executive Officer of Soliton.

Key Points: 
  • HOUSTON, Nov. 2, 2020 /PRNewswire/ --Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary aesthetic platform technology, today announced the appointment of Brad A. Hauser as President and Chief Executive Officer of Soliton.
  • As a long-standing member of our Board, Brad has provided excellent guidance and insight for the Soliton pipeline.
  • We are very encouraged by the commercialization experience and skill set he brings to the CEO role," Walter Klemp, Soliton Co-Founder and Executive Chairman commented.
  • Mr. Hauser's extensive knowledge of the aesthetic market stems from his many years of valuable industry experience.

Soliton Appoints Niquette Hunt to Board of Directors

Retrieved on: 
Thursday, October 22, 2020
Calculus, Differential equations, Multivariable calculus, Quasiparticles, Solitons, Hyperhidrosis

HOUSTON, Oct. 22, 2020 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary aesthetic platform technology, today announced the appointment of Niquette Hunt to its Board of Directors.Ms.

Key Points: 
  • HOUSTON, Oct. 22, 2020 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary aesthetic platform technology, today announced the appointment of Niquette Hunt to its Board of Directors.Ms.
  • "We are thrilled to add Ms. Hunt to our Board of Directors," commented Dr. Christopher Capelli, Soliton Co-Founder and CEO.
  • Ms. Hunt brings more than 25 years of general management and commercialization experience leading consumer product and biotechnology companies.
  • Ms. Hunt founded Candesant Biomedical in 2016 to develop a novel, non-invasive treatment for those who suffer from excessive sweating.

244% Percent Return on Investment for Peakon Customers, Total Economic Impact Study Reveals

Retrieved on: 
Thursday, October 1, 2020
Computing, Articles, Solitons, Business, Peakon, Forrester, Dashboard

COPENHAGEN, Denmark,LONDON, AUCKLAND, NewZealand,BERLIN and NEW YORK, Oct. 1, 2020 /PRNewswire/ -- Peakon an employee success platform today released a commissioned Total Economic Impact study, conducted by Forrester Consulting, which quantifies the benefits and returns of using Peakon.

Key Points: 
  • COPENHAGEN, Denmark,LONDON, AUCKLAND, NewZealand,BERLIN and NEW YORK, Oct. 1, 2020 /PRNewswire/ -- Peakon an employee success platform today released a commissioned Total Economic Impact study, conducted by Forrester Consulting, which quantifies the benefits and returns of using Peakon.
  • When interviewed for the study, one enterprise customer from the recruitment sector said: "The Peakon platform drives engagement results to managers directly through the dashboard.
  • We believe that this study by Forrester Consulting just proves it further by quantifying the impact Peakon can have on businesses worldwide."
  • Forrester developed the Total Economic Impact of Peakon, commissioned by Peakon, through four enterprise customer interviews at organizations using Peakon to obtain data with respect to costs, benefits, and risks, and subsequent financial analysis.

244% Percent Return on Investment for Peakon Customers, Total Economic Impact Study Reveals

Retrieved on: 
Thursday, October 1, 2020
Articles, Business, Computing, Workplace, Industrial and organizational psychology, Solitons, Working time, Peakon, Absenteeism, Dashboard

Estimated savings of $755,000 as a result of reduced employee absenteeism, with average absenteeism declining by two days after the first year with Peakon.

Key Points: 
  • Estimated savings of $755,000 as a result of reduced employee absenteeism, with average absenteeism declining by two days after the first year with Peakon.
  • When interviewed for the study, one enterprise customer from the recruitment sector said: "The Peakon platform drives engagement results to managers directly through the dashboard.
  • We believe that this study by Forrester Consulting just proves it further by quantifying the impact Peakon can have on businesses worldwide."
  • Forrester developed the Total Economic Impact of Peakon, commissioned by Peakon, through four enterprise customer interviews at organizations using Peakon to obtain data with respect to costs, benefits, and risks, and subsequent financial analysis.